Innate lymphoid cells (ILCs) regulate stromal cells, epithelial cells and cells of the immune system, but their effect on B cells remains unclear. Here we identified RORgt + ILCs near the marginal zone (MZ), a splenic compartment that contains innate-like B cells highly responsive to circulating T cell-independent (TI) antigens. Splenic ILCs established bidirectional crosstalk with MAdCAM-1 + marginal reticular cells by providing tumor-necrosis factor (TNF) and lymphotoxin, and they stimulated MZ B cells via B cell-activation factor (BAFF), the ligand of the costimulatory receptor CD40 (CD40L) and the Notch ligand Delta-like 1 (DLL1). Splenic ILCs further helped MZ B cells and their plasma-cell progeny by coopting neutrophils through release of the cytokine GM-CSF. Consequently, depletion of ILCs impaired both pre-and post-immune TI antibody responses. Thus, ILCs integrate stromal and myeloid signals to orchestrate innate-like antibody production at the interface between the immune system and circulatory system.
The spleen is a highly perfused organ specialized in host defense against blood-borne antigens. Interposed between the follicles of the splenic white pulp and the circulation, the marginal zone (MZ) contains B cells enmeshed with macrophages and dendritic cells (DCs) in a stromal reticular cell network [1] [2] [3] . All of those cells provide efficient immunosurveillance of the circulatory system by readily interacting with circulating antigens owing to the slow flow rate of the blood passing through the MZ 4 . Following antigen capture, macrophages, DCs and possibly neutrophils of the innate immune system expose antigen to MZ B cells, a unique subset of antibody-producing lymphocytes that develop from transitional B cells in response to signals from the Notch2 signaling receptor 5 .
Lymphoid sites positioned between the host and the environment contain innate-like B cells and T cells that belong to the adaptive immune system but share several properties with effector cells of the innate immune system. Mucosal and serosal membranes include innate-like B-1 cells that generate a first line of protection through the early production of low-affinity immunoglobulin M (IgM) in response to bacteria 6 . When microbes breach the mucosal barrier and enter the general circulation, innate-like MZ B cells provide a second line of protection via low-affinity IgM and IgG that bridge the temporal gap required for the slower production of high-affinity IgG by follicular (FO) B cells 4 .
Similar to B-1 cells, MZ B cells express clonally distributed and somatically recombined but rather nonspecific B cell antigen receptors (BCRs) encoded by poorly diversified immunoglobulin genes 4, 6 . MZ B cells also express nonclonally distributed and germline-encoded Toll-like receptors (TLRs) 7 , a subfamily of nonspecific microbe sensors generally known as 'pattern-recognition receptors' . Typically expressed by effector cells of the innate immune system, TLRs activate MZ B cells after recognizing conserved microbial molecular signatures in cooperation with BCRs 8 . The activation of MZ B cells is further enhanced by B cell-stimulating cytokines released by DCs, macrophages and neutrophils 9, 10 .
In addition to containing innate-like lymphocytes, mucosal surfaces have innate lymphoid cells (ILCs) that express neither somatically recombined antigen receptors nor phenotypical markers of myeloid cells 11 . Those ILCs require the transcriptional repressor Id2 and the cytokine interleukin 7 (IL-7) for their development, and they generate cytokine-secretion patterns that mirror those of helper T cells of the adaptive immune system 12, 13 . Similar to proinflammatory T helper type 1 cells, ILCs of group 1 release interferon-γ (IFN-γ) and require the transcription factor T-bet for their development, as do natural killer (NK) cells of the innate immune system 14 . ILCs of group 2, which include natural helper cells and nuocytes, secrete IL-5 and IL-13 and require the transcription factor GATA-3 and thus resemble proinflammatory T helper type 2 cells [15] [16] [17] . Finally, ILCs of group 3 (ILC3 cells) require the transcription factors RORγt and AhR and include not only mucosal 'NK-22' cells, which secrete IL-22 and thus mimic noninflammatory cells of the T H 22 subset of helper T cells [18] [19] [20] [21] , but also fetal and mucosal lymphoid tissue-inducer cells (LTi cells), which produce IL-22 and IL-17 and thus resemble proinflammatory cells of the T H 17 subset of helper T cells [22] [23] [24] . While NK-22 cells express natural cytotoxicity receptors (NCRs) usually associated with NK cells and mediate mucosal homeostasis by targeting epithelial cells via IL- 22 (refs. 25-27) , LTi cells lack NCRs and promote fetal lymphoid organogenesis and postnatal mucosal immunity by targeting stromal cells via lymphotoxin and tumor-necrosis factor (TNF) [28] [29] [30] .
Mucosal NK-22 cells, also defined as 'NCR + ILC3 cells' to distinguish them from inflammatory NCR − ILC3 cells characterized by the constitutive production of IL-17 and IL-22 and activation-induced production of IFN-γ 31, 32 , express B cell-activating factor (BAFF) 20 , a cytokine of the TNF family used by DCs, macrophages and neutrophils to help MZ B cells and plasma cells in a T cell-independent (TI) manner 1, 9, 10 . BAFF and its homolog APRIL are related to the ligand of the costimulatory receptor CD40 (CD40L), a member of the A r t i c l e s TNF family used by follicular helper T cells to activate FO B cells 33 . Given their involvement in the mucosal production of TI antibodies 29, 34 , ILCs might also regulate humoral immunity in the MZ, a lymphoid area that is continually exposed to antigen, as are mucosal membranes.
Here we identified ILCs with mucosa-like properties in the MZ and perifollicular zone of the spleen. These ILCs required survival signals from marginal reticular cells (MRCs), a MZ subset of stromal cells that responded to TNF and lymphotoxin from ILCs. In addition to stimulating MZ B cells and plasma cells via BAFF, APRIL, CD40L and the Notch2 ligand Delta-like 1 (DLL1), splenic ILCs coopted MZ B cell-helper neutrophils via the cytokine GM-CSF (CSF2). Consequently, depletion of ILCs hampered the production of antibodies by MZ B cells in response to TI antigens.
RESULTS

Splenic ILCs have type 3 mucosal features
The MZ is continually exposed to blood-borne antigens and may thus require homeostatic signals from ILCs, as mucosal membranes do 4 . Flow cytometry showed that histologically normal adult human 
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A r t i c l e s spleens contained cells that lacked common molecules associated with the lymphoid and myeloid lineage (Lin − ) but expressed the receptor for IL-7 (CD127) and the receptor for stem cell growth factor (CD117) ( Fig. 1a and Supplementary Fig. 1a ). These ILCs resembled mucosal NCR + ILC3 cells 19, 20 , because they expressed the NK cell-related molecules CD56, CD96, CD161, NKp44 and NKp46, the chemokine CCL20 receptor CCR6, the activation molecules CD25 and CD69, and Notch2 ( Fig. 1a and Supplementary Figs. 1b). Splenic ILCs expressed neither the coreceptor CD8, which is associated with cytotoxic T cells, nor the integrin CD103, which is expressed by some mucosal lymphocytes, and did not express the coreceptor CD4 or the prostaglandin D 2 receptor CRTH2 ( Fig. 1a and Supplementary Fig. 1b ), which are expressed by mouse LTi cells and human ILCs of group 2, respectively 16, 22 . Although they expressed as much CD161 as NK cells did, splenic ILCs had higher expression of NKp44, CCR6 and CD96 but lower expression of NKp46 than NK cells had ( Supplementary Fig. 1c ).
Analysis of gene expression by quantitative RT-PCR showed that splenic ILCs expressed the transcription factors RORγt, AhR and Id2, the cytokines IL-22, IL-26, lymphotoxin-α (LT-α), LT-β and TNF and the receptor for IL-23, whereas splenic NK cells, T cells and macrophages did not, except that B cells had abundant expression of LT-β ( Fig. 1b and Supplementary Fig. 1d ). Compared with mucosal ILCs from tonsils, splenic ILCs had similar expression of RORγt and AhR, but lower expression of IL-22 and higher expression of LT-α, LT-β and TNF ( Fig. 1b) . Those last three cytokines, together with IL-17, are also hallmarks of LTi cells 23, 30 . However, splenic ILCs lacked expression of IL-17, which we detected instead in T cells ( Supplementary   Fig. 1d ). Of note, splenic ILCs included CD56 + and CD56 − subsets with overlapping ILC3 gene-expression profiles that did not include expression of the genes encoding IFN-γ or perforin-1, which instead had abundant expression in NK cells ( Fig. 1b and Supplementary  Fig. 1e,f) . Flow cytometry showed that splenic RORγt + ILCs lacked T-bet, a transcription factor that was instead expressed by RORγt − NK cells ( Fig. 1c) .
Flow cytometry and enzyme-linked immunosorbent assay (ELISA) demonstrated that splenic ILCs were more abundant than were mucosal ILCs ( Fig. 1d ) and had properties of NCR + ILC3 cells 19, 20 . Indeed, splenic ILCs received antiapoptotic signals from the stromal cytokine IL-7 and the innate cytokines IL-1β and IL-23 and secreted IL-22 in response to IL-1β and IL-23, as did mucosal ILCs (Fig. 1e,f) . Finally, tissue immunofluorescence analysis (IFA) and immunohistochemistry (IHC) showed that RORγt + NKp44 + CD117 + tryptasenegative ILCs occupied MZ and perifollicular zone areas and were distinct from CD117 + tryptase-positive mast cells and CD3 + RORγt − NKp44 − T cells (Fig. 1g,h and Supplementary Fig. 2a-d) . Some ILCs were also present in the periarteriolar lymphoid sheath (data not shown). Thus, the human spleen contained mucosalike ILCs that were different from NK cells and were positioned near MZ B cells.
Splenic ILCs receive survival signals from MRCs
Given that LTi cells interact with stromal cells via lymphotoxin and TNF 22, 29, 30 , we sought to identify stromal cells in the human MZ by tissue IFA, IHC and flow cytometry. We detected fibroblast-like cells that expressed the integrin α 4 β 7 ligand MAdCAM-1 in the MZ near 
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A r t i c l e s IgD + B cells and some RORγt + ILCs ( Fig. 2a and Supplementary  Fig. 3a ). Those MAdCAM-1 + cells did not express the coagulation protein von Willebrand factor, which characterizes endothelial cells, whereas MAdCAM-1 − sinusoid-lining cells from the red pulp did ( Fig. 2a) . MAdCAM-1 + cells also lacked the endothelial molecules CD31 (PECAM-1) and CD34, as well as the leukocyte molecule CD45, but expressed the stromal molecules Thy-1 (CD90), CD141 (thrombomodulin), ICAM-1, VCAM-1 and α-smooth muscle actin ( Fig. 2b and Supplementary Fig. 3b,c) , and thus we considered them equivalent to mouse MRCs 3 .
Human MRCs expressed TLR3 (which binds double-stranded RNA), TLR4 (which binds lipopolysaccharide (LPS)) and TLR9 (which binds unmethylated CpG-rich DNA) ( Fig. 2b) . This was indicative of a role for microbial products in the regulation of MRCs. Laser-capture microdissection followed by quantitative RT-PCR demonstrated that MAdCAM-1 + tissue enriched for MRCs contained more ILC survival factors (such as IL-1β, IL-7 and IL-23) and more ILC-recruiting factors (such as CCL20 (a ligand for CCR6)) than did tissue enriched for sinusoid-lining cells and positive for the endocytic mannose receptor or control tissue negative for the mannose receptor ( Fig. 2c) .
As shown by flow cytometry, splenic ILCs upregulated expression of the MAdCAM-1-binding integrin α 4 β 7 in response to IL-7 and IL-1β ( Fig. 2d) , which indicated a role for the MAdCAM-1-α 4 β 7 interaction in the perifollicular positioning of ILCs. Conversely, MRCs upregulated expression of ICAM-1 and VCAM-1 in response to splenic ILCs or a combination of lymphotoxin and TNF or LPS ( Fig. 2e and Supplementary Fig. 3d,e) . Blocking experiments and quantitative RT-PCR indicated that ILCs activated MRCs via lymphotoxin and TNF ( Fig. 2f and Supplementary Fig. 3f ), whereas MRCs upregulated expression of IL-7, CCL20 and MAdCAM-1 in response to lymphotoxin and TNF (Supplementary Fig. 3g ). Of note, Transwell assays showed that MRCs supported the survival of ILCs via contact-dependent and contact-independent signals that included IL-7 ( Fig. 2g,h) . Finally, splenic macrophages and DCs had higher expression of IL-1β and IL-23 than did MRCs (Supplementary Fig. 3h ), which suggested that ILCs established bidirectional interaction with MRCs in splenic niches that may have also entailed cells of the innate immune system.
Splenic ILCs and MRCs deliver B cell-helper signals
Given their MZ and perifollicular location, human splenic ILCs may regulate MZ B cells. As shown by tissue IFA and quantitative RT-PCR, splenic RORγt + ILCs were positioned near CD20 + B cells and had higher expression of BAFF, CD40L and DLL1, three major factors for the provision of help to B cells and plasma cells 5, 9, 10, 35 , than that of other splenic leukocyte subsets or mucosal ILCs (Fig. 3a,b) . 
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Unlike splenic macrophages, splenic ILCs had little or no expression of APRIL (Fig. 3b) , a BAFF-related plasma cell-survival factor 36 . As shown by flow cytometry and ELISA, splenic ILCs had surface expression of BAFF, CD40L and DLL1 and secreted BAFF, whereas APRIL was secreted mainly by macrophages ( Fig. 3c,d) . Accordingly, splenic ILCs stimulated the survival, proliferation, IgM secretion and plasmablast differentiation of IgD lo CD27 + MZ B cells but not of IgD hi CD27 − FO B cells ( Fig. 3e-g) . Having shown that MRCs provided survival and activation signals to ILCs, we investigated whether MRCs augmented the B cell-helper function of ILCs. MZ B cells exposed to both ILCs and MRCs not only underwent more IgM secretion and plasmablast differentiation than did MZ B cells exposed to ILCs or MRCs alone but also acquired the ability to release IgG and IgA, particularly in the presence of CpG DNA (Fig. 3f,g) . Thus, human splenic ILCs may integrate stromal signaling and signaling of the innate immune system to orchestrate antibody production.
Splenic ILCs help MZ B cells via BAFF, CD40L and DLL1
Next we used flow cytometry and ELISA to determine the mechanism by which human splenic ILCs help MZ B cells. BAFF-R-Ig, a soluble decoy receptor that blocks the binding of BAFF to B cells, attenuated the survival of MZ B cells exposed to ILCs (Fig. 4a) . Of note, MZ B cells underwent plasmablast differentiation and IgM secretion in response to ILCs but not in response to ILC-conditioned medium (Fig. 4b,c) , which suggested the involvement of contact-dependent signals from membrane-bound BAFF, CD40L and/or DLL1. Accordingly, BAFF-R-Ig, CD40-Ig (a decoy receptor that blocks the binding of CD40L to B cells) or an inhibitor of Notch signaling mitigated the ILC-induced secretion of IgM, particularly when we used those inhibitors in combination (Fig. 4d) .
Although it is required for the early development of MZ B cells, Notch2 continues to be expressed on mature MZ B cells and may thus modulate their function 5 . Indeed, when combined with BAFF, DLL1-expressing OP9 stromal cells stimulated plasma-cell differentiation and IgM secretion (through Notch signaling) in MZ B cells ( Fig. 4e-g) . In contrast, BAFF alone or combined with DLL1negative OP9 cells had little or no stimulatory effect ( Fig. 4e-g) .
Thus, in addition to eliciting the survival and activation of MZ B cells, human splenic ILCs promoted plasmablast differentiation and survival via BAFF, CD40L and DLL1.
Splenic ILCs activate perifollicular neutrophils via GM-CSF
In human spleens, MZ B cells interact with neutrophils ('N BH cells') that possibly originate from circulating precursors ('N C cells') 10 . Given 
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A r t i c l e s the involvement of RORγt in GM-CSF expression by T H 17 cells and the importance of GM-CSF in the activation and survival of neutrophils 37 , we sought to determine whether splenic ILCs expressed GM-CSF. Tissue IHC showed CD117 + ILCs near CD66 + (CEACAM-1 + ) N BH cells positioned around the MZ (Fig. 5a) . Quantitative RT-PCR, ELISA and flow cytometry demonstrated abundant expression of GM-CSF in splenic ILCs but not in other leukocyte subsets (Fig. 5b,c) . Splenic ILCs further expressed the neutrophil-recruiting chemokine IL-8 (CXCL8), which was also produced by macrophages and NK cells, albeit in smaller amounts (Fig. 5b,c) .
Given that GM-CSF enhances the B cell-helper function of neutrophils 10 , we used flow cytometry, ELISA, IFA and quantitative RT-PCR to establish whether GM-CSF-producing splenic ILCs induced N BH cell-like properties in N C cells. In the presence of splenic ILCs, N C cells not only acquired phenotypic traits typical of N BH cells 10 , such as upregulation of expression of the activation molecules CD69, CD11b and CD24 and downregulation of expression of the adhesion molecule CD62L, but also received survival signals from GM-CSF (Fig. 5d,e ).
When incubated with splenic ILCs or their conditioned medium, N C cells upregulated expression of APRIL and thus stimulated IgA production in MZ B cells (Fig. 5f,g) . ILC-conditioned medium also augmented the capacity of N BH cells to induce IgM, IgG and IgA in MZ B cells (Fig. 5h) . Similar to GM-CSF or LPS, ILC-conditioned medium stimulated N C cells to form neutrophil extracellular traps (Fig. 5i) , which are antigen-trapping projections that often emanate from N BH cells 10 . Thus, human splenic ILCs may amplify the responses of MZ B cells by stimulating perifollicular neutrophils via GM-CSF.
Splenic ILCs enhance the TI production of antibodies
To elucidate the contributions of splenic ILCs to humoral immunity in vivo, we initially took advantage of Rorc −/− mice, which lack RORγt, the transcription factor required for the development of ILC3 cells 22, 28 . Rorc −/− mice also lack T H 17 cells, a subset of CD4 + T cells that regulate neutrophils via IL-17 and GM-CSF [37] [38] [39] . Flow cytometry showed that Rorc −/− mice had fewer splenic Lin − CD117 + CD127 + ILCs than did Rorc +/+ (wild-type) mice (Fig. 6a) . Flow cytometry and quantitative npg RT-PCR demonstrated that in those wild-type mice, splenic ILCs included both CD4 + and CD4 − subsets that had higher expression of RORγt, IL-22, LT-α and TNF than that of other splenic leukocytes ( Fig. 6b and Supplementary Fig. 4a) . In contrast to human splenic ILCs, mouse splenic ILCs lacked expression of BAFF and CD40L but expressed APRIL and DLL1 (Fig. 6b) .
We then investigated whether Rorc −/− mice had an altered MZ. As shown by tissue IFA, Rorc −/− mice had no perturbation of MOMA-1 + metallophilic macrophages, ER-TR9 + (SIGN-R1 + ) MZ macrophages or ICAM-1 + marginal sinus cells from the MZ, IgM + B cells from the MZ and white pulp, or F4/80 + macrophages or VCAM-1 + endothelial cells from the red pulp (Supplementary Fig. 4b ). Flow cytometry, tissue IFA and ELISA demonstrated that spleens from Rorc −/− mice that were not immunized had conserved B cells but fewer plasmablasts and plasma cells that expressed IgG3, an antibody produced by MZ B cells through a TI pathway under preimmune conditions or after immunization 40, 41 , than did their Rorc +/+ counterparts (Fig. 6c,d and Supplementary Fig. 5a ). In addition to having lower total serum concentrations of IgG3, Rorc −/− mice had lower serum concentrations of preimmune IgG3 naturally reactive to the bacterial TI antigen phosphorylcholine (Fig. 6e,f) . To ascertain the relative contribution of ILCs and T cells to preimmune IgG3 responses, we crossed Rorc +/− and Rorc −/− mice with T cell-deficient Cd3e −/− mice. In agreement with the TI nature of preimmune IgG3 production 40, 41 , Rorc +/− Cd3e −/− mice that were not immunized had a normal abundance of splenic B cells, plasma cells and plasmablasts that expressed IgG3 (Fig. 6g) . Rorc −/− Cd3e −/− mice had fewer plasmablasts and plasma cells that expressed IgG3 and lower preimmune serum concentrations of IgG3 than did Rorc +/− Cd3e −/− mice (Fig. 6g,h) .
Unlike the preimmune serum concentrations of IgG3, those of IgM were augmented in Rorc −/− mice, together with splenic IgM hi B220 int-lo CD5 int B-1 cells but not B220 + CD21 + CD23 + FO B cells or B220 + CD21 hi CD23 − MZ B cells (Supplementary Fig. 5b,c) . The population expansion of IgM-producing B-1 cells in Rorc −/− mice may have resulted from enhanced migration of B-1 cells from the peritoneal cavity to the spleen due to the lack of gut-associated lymphoid tissue and increased systemic translocation of gut bacteria 22, 28, 34, 42 . Nonetheless, Rorc −/− mice had lower preimmune serum concentrations of IgM naturally reactive to phosphorylcholine than did their Rorc +/+ counterparts (Supplementary Fig. 5d ), which suggested a role for ILCs in at least some TI IgM responses.
To delineate the MZ B cell-helper function of ILCs in a more physiological model, we used an antibody to Thy-1.2 (anti-Thy-1.2) to achieve depletion of ILCs in Thy-1-disparate Rag1 −/− chimeras generated as described 43 . Mice treated with anti-Thy-1.2 had fewer splenic ILCs, fewer IgG3-expressing plasmablasts and plasma cells and lower preimmune serum concentrations of IgG3 than did mice treated with a control antibody (Fig. 7a-c and Supplementary Fig. 5e ). Furthermore, mice treated with anti-Thy-1.2 had impaired post-immune IgG3 responses to TNP-Ficoll (the hapten TNP (2,4,6-trinitrophenyl) linked to the hydrophilic polysaccharide Ficoll) (Fig. 7d) , a TI antigen that induces antibody production in innate-like B cells, including MZ B cells 40 .
We also demonstrated the involvement of splenic ILCs in the TI production of antibodies in mixed chimeras generated by the reconstitution of lethally irradiated Rorc −/− mice with a mixture of bone marrow cells from Rag1 −/− mice (which generate ILCs but not T cells or B cells) and Rorc −/− mice (which generate T cells and B cells but not ILCs). ILC-sufficient (ILC + ) mixed chimeras developed splenic ILCs, whereas ILC − control chimeras (generated by the reconstitution of irradiated Rorc −/− mice with bone marrow cells from Rorc −/− mice) did not (Fig. 7e) . ILC − control chimeras had fewer splenic A r t i c l e s plasmablasts and plasma cells that expressed IgG3 and lower preimmune serum concentrations of IgG3 than did ILC + mixed chimeras ( Fig. 7f,g) . In all mouse models, IgM responses were affected only marginally (data not shown), which indicated that splenic ILCs helped mainly IgG3-expressing plasmablasts and plasma cells emerging from MZ B cell responses to TI antigens.
Splenic ILCs regulate neutrophil homeostasis
We next investigated the role of mouse splenic ILCs in the homeostasis of N BH cells. Tissue IFA and flow cytometry showed that ILC − control chimeras had fewer splenic Ly6G + CD11b + neutrophils and extrafollicular IgG3-producing plasmacytes than did ILC + mixed chimeras (Fig. 8a,b) . Rorc −/− mice on either a T cell-sufficient background or a T cell-deficient background also had fewer splenic neutrophils than did Rorc +/+ mice (Supplementary Fig. 6a-c) , which indicated that splenic ILCs provided helper signals to neutrophils independently of T cells. To ascertain the contribution of splenic neutrophils to preimmune IgG3 production, we depleted ILC + mixed chimeras of splenic neutrophils with anti-Ly6G (Fig. 8c) . Those mice had a normal abundance of splenic ILCs and IgG3-expressing B cells and plasmablasts but fewer splenic IgG3-expressing plasma cells and lower preimmune serum concentrations of IgG3 than did their ILC + mixed counterparts treated with a control antibody ( Fig. 8d-f) . Thus, unlike ILCs, neutrophils may control mainly terminally differentiated IgG3-secreting cells. Finally, we determined whether splenic ILCs regulate neutrophils via GM-CSF. As shown by quantitative RT-PCR, splenic ILCs from wild-type mice had higher expression of GM-CSF than that of other leukocyte subsets, including macrophages and NK cells (Fig. 8g) . GM-CSF-deficient (Csf2 −/− ) mice had lower preimmune serum concentrations of IgM antibodies to bacterial phosphorylcholine and fewer splenic neutrophils than did wild-type mice, and those neutrophils increased in abundance after inoculation of the Csf2 −/− mice with B16 melanoma cells expressing GM-CSF ( Fig. 8h and  Supplementary Fig. 6d) . Also, Rag1 −/− Il2rg −/− mice, which lack the IL-2 receptor (common γ-chain) mandatory for the IL-7-dependent development of ILCs 13 , had fewer splenic neutrophils than did their Rag1 −/− Il2rg +/+ control counterparts (Fig. 8i) . Moreover, adoptive transfer of ILCs from Csf2 +/+ increased the abundance of splenic neutrophils in Rag1 −/− Il2rg −/− mice, but adoptive transfer of ILCs from Csf2 −/− mice did not (Fig. 8i) . Thus, in addition to helping MZ B cells and plasma cells through BAFF (or APRIL), CD40L and DLL1, splenic ILCs coopted neutrophils via GM-CSF to enhance the TI production of antibodies ( Supplementary Fig. 7a,b) . 
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-/-II2rg npg DISCUSSION We have shown that the MZ and perifollicular zone of the spleen contained mucosa-like ILC3 cells that released lymphotoxin and TNF to establish bidirectional crosstalk with stromal MRCs. Splenic ILCs stimulated MZ B cells and plasma cells through BAFF, APRIL, CD40L and DLL1. They also coopted neutrophils with MZ B cell-and plasma cell-helper functions through GM-CSF and thereby sustained the TI production of antibodies. Mucosal and serosal membranes contain evolutionarily primitive lymphocyte subsets that include B-1 cells, γδ T cells, invariant NKT cells and mucosa-associated invariant T cells 44 . By sensing conserved microbial signatures through somatically recombined and germlineencoded receptors, those innate-like lymphocytes rapidly activate protective programs that cross over the conventional boundaries between the innate immune system and adaptive immune system 44 . Mucosal membranes also contain ILCs that lack somatically recombined receptors and yet mount prompt T cell-like responses 13 . Here we found that splenic ILCs enhanced antibody production in response to TI antigens by activating innate-like B cells positioned at the interface between the immune system and circulatory system.
Similar to mucosal ILC3 cells 19, 20 , human splenic ILCs expressed both RORγt and AhR, as well as NCRs and various activation molecules, and secreted IL-22 in response to IL-23. In addition, human splenic ILCs activated MZ-based stromal MRCs via lymphotoxin and TNF and thus also resembled fetal or mucosal LTi cells [28] [29] [30] 45 . However, unlike LTi cells 23, 30 , human splenic ILCs did not express IL-17, which raises questions about the ontogenetic relationships between these ILC subsets. Mouse splenic ILCs had a phenotype and gene-expression profile similar to those of human splenic ILCs but expressed CD4 and thus showed closer affiliation with LTi cells.
Human splenic ILCs not only expressed the gut-homing receptor α 4 β 7 but also interacted with MRCs equipped with MAdCAM-1, an α 4 β 7 ligand usually associated with gut endothelial cells 34 . Given their additional expression of the chemokine CCL20 and the presence of its receptor CCR6 on splenic ILCs, MRCs might be involved in the positioning of ILCs within and around the MZ. Consistent with their stromal phenotype and reticular morphology, MRCs lacked endothelial molecules and exhibited strong responsiveness to lymphotoxin and TNF from ILCs and thus resembled the MAdCAM-1 + stromal cells that line the mouse marginal sinus 46 . Conversely, MRCs delivered both contact-dependent survival signals and contact-independent survival signals, including IL-7, to ILCs. Notably, MRCs increased their IL-7 expression in response to lymphotoxin and TNF, which indicated the presence of bidirectional functional crosstalk between MRCs and ILCs in the MZ and perifollicular zone of the spleen. Additional ILC survival factors, such as IL-1β and IL-23, were expressed mainly by splenic DCs and macrophages, which suggested that ILCs inhabit a splenic niche that generates ILC survival signals through both stromal cells and cells of the immune system. Of note, MRCs received further activation signals from TLR ligands such as LPS, which lends support to the possibility that commensal antigens from the intestinal mucosa help the postnatal development and function of the splenic MZ 4, 10, 47, 48 .
In humans, splenic ILCs enhanced the survival of MZ B cells through a contact-independent mechanism that involved soluble BAFF but triggered the differentiation of MZ B cells into plasmablasts through contact-dependent signals provided by membrane-bound BAFF, DLL1 and CD40L. Of note, DLL1 acted in synergy with soluble BAFF to induce IgM secretion, possibly owing to the prosurvival effect of soluble BAFF on plasmablasts 35 . Given that DLL1 also acts together with BAFF to stimulate the early development of MZ B cells 5 , it is possible that DLL1 on ILCs operates at both early and late stages of MZ B cell differentiation with distinct signaling programs. Of note, splenic ILCs further helped MZ B cells by coopting N BH cells through GM-CSF. That cytokine may also enhance the MZ B cell-stimulating function of DCs and possibly macrophages 1, 4 , which may explain why a relatively small number of ILCs was sufficient to enhance TI antibody responses.
Despite expressing CD40L, a class switch-inducing factor typically detected on follicular helper T cells 33 , human splenic ILCs did not trigger the production of IgG or IgA in MZ B cells. Nonetheless, MZ B cells induced the production of IgA and IgG when exposed to ILCs in the presence of MRCs and microbial TLR ligands. Accordingly, small amounts of those bacterial components can be detected in splenic perifollicular areas, together with plasma cells that release IgM, IgG or IgA 10 . Thus, similar to gut LTi cells 29 , splenic ILCs may integrate stromal signals and signals from the innate immune system to rapidly generate antibodies for antimicrobial protection.
Although they lacked both CD40L and BAFF, mouse splenic ILCs expressed APRIL, a BAFF-related molecule that enhances plasmacell survival 36 . By also expressing DLL1, mouse splenic ILCs would sustain the differentiation and/or survival of plasmablasts and plasma cells that emerge during IgG3 responses to TI antigens. In mice, depletion of ILCs did not impair IgM production, which suggests that ILCs enhance mainly MZ B cell-derived IgG3 responses rather than B-1 cell-derived IgM responses. Nonetheless, splenic ILCs sustained preimmune production of IgM in response to bacterial phosphorylcholine, which indicated the involvement of ILCs in IgM responses to some but not all TI antigens.
In ILC-deficient mice, impaired TI production of IgG3 was associated with fewer N BH cells, which help MZ B cells via BAFF and APRIL 10 . Accordingly, human splenic ILCs enhanced the survival and B cell-helper activity of N BH cells through GM-CSF. That cytokine also induced structures similar to neutrophil extracellular traps, which might enable N BH cells to capture blood-borne antigens transiting through the MZ 4, 10 . Human splenic ILCs also released IL-8, which may contribute to the recruitment of N BH cells. Mice do not express IL-8, but their splenic ILCs may attract N BH cells via alternative factors, including GM-CSF. Notably, splenic 'innate response-activator' B cells also express GM-CSF 49 , which could explain the persistence of some N BH cells in mice that lack ILCs.
GM-CSF further derives from T H 17 cells 37 , but our analysis of T cell-deficient mice suggested that ILCs can regulate the homeostasis of N BH cells independently of T cells. In mice, splenic ILCs sustained both IgG3 + plasmablasts and IgG3 + plasma cells, whereas mouse N BH cells helped mainly IgG3 + plasma cells, which suggested that multiple cell subsets of the innate immune system orchestrate TI IgG3 responses in a hierarchical manner. Of note, IgG3 may provide protection against certain pathogens following its interaction with ficolins, a family of soluble pattern-recognition receptors released by hepatocytes and various cells of the innate immune system 41 . In summary, our studies have indicated that splenic ILCs orchestrate a stromal cell-innate cell network that fosters the TI production of antibodies by MZ B cells. Harnessing this network with adjuvants may enhance protective humoral responses to poorly immunogenic TI antigens 4, 50 , including viral glycoproteins and bacterial carbohydrates.
METHODS
Methods and any associated references are available in the online version of the paper. npg Flow cytometry. Cells were incubated at 4 °C with Fc-blocking reagent (Miltenyi Biotec) before the addition of the appropriate 'cocktails' of fluorochrome-labeled mAbs (Supplementary Tables 1 and 2) . Dead cells were excluded through the use of DAPI (4′-6-diamidine-2′-phenylindole) as indicated by the manufacturer (Boehringer Mannheim). For analysis of intracellular transcription factors, human ILCs or NK cells were stained with mAbs to cell-specific surface molecules ( Supplementary Table 1 ) and were identified as CD3 − CD14 − CD19 − CD117 + CD127 + (ILCs) or CD3 − CD14 − CD19 − CD117 − C D127 − CD56 + (NK cells), then were permeabilized, fixed with a Transcription Factor Buffer Set as indicated by the manufacturer (eBioscience) and labeled with mAb to human RORγt or mAb to T-bet (each in Supplementary Table 1) . For intracellular staining of cytokines, human ILCs were cultured for 4 h in complete RPMI medium with GolgiStop (BD Pharmingen) in the presence or absence of 100 nM phorbol myristate acetate and 0.5 µg/ml ionomycin (Sigma). Those cells were stained with mAbs to specific surface molecules, fixed, permeabilized using the Cytofix/Cytoperm kit (BD Pharmingen), and finally incubated with mAb to human GM-CSF or IL-8 (each in Supplementary  Table 1 ). To stain intracellular IgG3, mouse splenocytes were stained with mAbs to specific surface molecules (Supplementary Table 2) , permeabilized, fixed with the Cytofix/Cytoperm kit (BD Pharmingen), and labeled with mAb R40-82 to mouse IgG3 (Supplementary Table 2 ). Cells were acquired with a FACSCalibur, FACSAria II, LSR II or LSRFortessa (BD Biosciences) and data were further analyzed with FlowJo software (TreeStar).
Sorting of cells by flow cytometry.
Human CD3 − CD14 − CD19 − CD11 7 + CD127 + ILCs, CD3 − CD14 − CD19 − CD117 − CD127 − CD56 + NK cells, CD19 + IgD hi CD27 − naive B cells, CD19 + IgD lo CD27 + MZ B cells, CD14 + macrophages and CD3 + T cells, as well as mouse CD3 + T cells, B220 + B cells, CD11c + DCs, CD11b + macrophages, CD49b + NK cells, Ly6G + neutrophils, CD4 + CD45 + CD117 + CD127 + Lin − (CD3 − B220 − CD11b − CD11c − Ly6G − ) ILCs and CD4 − CD45 + CD117 + CD127 + Lin − ILCs, were stained with the appropriate 'cocktails' of fluorochrome-labeled mAbs (Supplementary Tables 1 and 2) and were sorted with a FACSAria II (BD Biosciences) after exclusion of dead cells through DAPI staining. The purity of cells sorted this way was consistently >95%.
Viability and proliferation assays. Cell survival was measured with Annexin-V Apoptosis Detection Kit II (BD Pharmingen). Gates and quadrants were drawn to give ≤1% total positive cells in samples incubated with isotypematched control mAbs. Cell proliferation was assessed by staining with CFSE (carboxyfluorescein diacetate succinimidyl ester) through the use of a CellTrace CFSE Cell Proliferation Kit (Invitrogen).
Laser-capture microdissection. For microdissection, fresh human splenic tissues were frozen in optimal cutting temperature compound with the ArcturusXT Laser Capture Microdissection System according to the manufacturer's instructions (Life Technologies). Then, tissue slices 10 µm in thickness were isolated on membrane slides (Life Technologies) and were
